This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions
by Zacks Equity Research
BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions are part of the Zacks Screen of the Week article.
5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes
by Maharathi Basu
Investors would do well to monitor broker-favored stocks like BTSG, BYON, ACDVF, DINO, and EBS for high returns.
Best Momentum Stock to Buy for May 14th
by Zacks Equity Research
BTSG made it to the Zacks Rank #1 (Strong Buy) momentum stock list on May 14, 2025.
New Strong Buy Stocks for May 14th
by Zacks Equity Research
BTSG, NVZMY, SWX, FTS and ULS have been added to the Zacks Rank #1 (Strong Buy) List on May 14, 2025.
What Makes BrightSpring Health Services, Inc. (BTSG) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does BrightSpring Health Services, Inc. (BTSG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Pediatrix Medical's Q1 Earnings Beat Estimates on Declining Costs
by Zacks Equity Research
MD anticipates adjusted EBITDA to be between $220 million and $240 million in 2025.
Select Medical Lags Q1 Earnings Estimates, Lowers Revenue Outlook
by Zacks Equity Research
SEM reiterates that earnings for 2025 are likely to be between $1.09 and $1.19 per share.
Can BrightSpring Health Services, Inc. (BTSG) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit
by Zacks Equity Research
Teladoc Health expects Integrated Care members to be between 101 million and 103 million in 2025.
Best Momentum Stocks to Buy for May 8th
by Zacks Equity Research
BTSG and UBSI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 8, 2025.
BrightSpring Health Services, Inc. (BTSG) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
New Strong Buy Stocks for May 8th
by Zacks Equity Research
BTSG, NWFL, MNRO, UBSI and IMCR have been added to the Zacks Rank #1 (Strong Buy) List on May 8, 2025.
Has BrightSpring Health Services, Inc. (BTSG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how BrightSpring Health Services, Inc. (BTSG) and Cencora (COR) have performed compared to their sector so far this year.
BrightSpring Health Services, Inc. (BTSG) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of 137.50% and 5.44%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for BrightSpring (BTSG) Stock Options
by Zacks Equity Research
Investors need to pay close attention to BrightSpring (BTSG) stock based on the movements in the options market lately.
BrightSpring Health Services, Inc. (BTSG) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of 15.79% and 0.35%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in BrightSpring Health Services, Inc. (BTSG) Stock?
by Zacks Equity Research
Investors need to pay close attention to BrightSpring Health Services, Inc. (BTSG) stock based on the movements in the options market lately.
BrightSpring Health Services, Inc. (BTSG) Soars 12.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta
by Zacks Equity Research
Doximity, BrightSpring Health Services and Embecta are part of the Zacks top Analyst Blog.
3 Medical Services Stocks to Buy to Counter Labor Shortage Woes
by Urmimala Biswas
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. DOCS, BTSG and EMBC are set to gain the most. However, healthcare staffing shortage is leading to an increase in labor wages.
What Makes BrightSpring Health Services, Inc. (BTSG) a New Strong Buy Stock
by Zacks Equity Research
BrightSpring Health Services, Inc. (BTSG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Can Teladoc (TDOC) Q2 Earnings Navigate BetterHelp Profit Woes?
by Zacks Equity Research
Teladoc's (TDOC) second-quarter results are likely to reflect lower advertising and marketing expenses.
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wall Street Analysts Think BrightSpring Health Services, Inc. (BTSG) Could Surge 38.15%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 38.2% upside potential for BrightSpring Health Services, Inc. (BTSG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.